Drug Shortage Report for MENVEO

Last updated on 2018-01-19 History
Report ID 29459
Drug Identification Number 02347393
Brand name MENVEO
Common or Proper name Meningococcal (Groups A, C, W-135 and Y) Oligosaccharide CRM197 Conjugate Vaccine
Company Name GLAXOSMITHKLINE INC
Active Ingredient(s) MENINGOCOCCAL GROUP C OLIGOSACCHARIDE CORYNEBACTERIUM DIPHTHERIAE CRM-197 PROTEIN MENINGOCOCCAL GROUP A OLIGOSACCHARIDE MENINGOCOCCAL GROUP Y OLIGOSACCHARIDE MENINGOCOCCAL GROUP W-135 OLIGOSACCHARIDE
Strength(s) 5MCG 47MCG 10MCG 5MCG 5MCG
Dosage form(s) SOLUTION POWDER FOR SOLUTION
Route of administration INTRAMUSCULAR
Packaging size 1 dose
ATC code J07AH
ATC description BACTERIAL VACCINES
Reason for shortage Delay in shipping of the drug.
Anticipated start date
Actual start date 2017-12-06
Estimated end date 2018-01-18
Actual end date 2018-01-17
Shortage status Resolved
Updated date 2018-01-19
Company comments Menveo 5 dose format still available. Supply disruptions may be seen in the private market.
Health Canada comments
Company contact information 1-800-387-7374

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v16 2018-01-19 French Compare
v15 2018-01-19 English Compare
v14 2018-01-12 French Compare
v13 2018-01-12 English Compare
v12 2017-12-21 French Compare
v11 2017-12-21 English Compare
v10 2017-12-20 French Compare
v9 2017-12-20 English Compare
v8 2017-12-07 English Compare
v7 2017-12-06 French Compare
v6 2017-12-06 English Compare
v5 2017-11-29 French Compare
v4 2017-11-29 English Compare
v3 2017-11-16 English Compare
v2 2017-11-16 French Compare
v1 2017-11-16 English Compare